methotrexate has been researched along with Labyrinth Diseases in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Gordis, TM; Rizk, HG; Shah, SR; Ward, C | 1 |
| Huang, KH; Lin, CD; Lin, HC; Wu, PC | 1 |
| Feld, J; Shupak, A; Zisman, D | 1 |
| Huang, NC; Sataloff, RT | 1 |
| Corman, LC; Cotter, CS; Singleton, GT | 1 |
| Jacewicz, M; McKown, KM; Ruckenstein, MJ | 1 |
| Roland, JT | 1 |
3 review(s) available for methotrexate and Labyrinth Diseases
| Article | Year |
|---|---|
Disease-Modifying Antirheumatic Drugs in the Treatment of Autoimmune Inner Ear Disease: A Systematic Review and Meta-Analysis of Auditory and Vestibular Outcomes.
Topics: Antirheumatic Agents; Autoimmune Diseases; Etanercept; Humans; Labyrinth Diseases; Methotrexate; Rituximab | 2023 |
Relapsing autoimmune inner ear disease with significant response to methotrexate and azathioprine combination therapy: A case report and mini literature review.
Topics: Adrenal Cortex Hormones; Adult; Autoimmune Diseases; Azathioprine; Female; Hearing Loss, Sensorineural; Humans; Immunosuppressive Agents; Labyrinth Diseases; Methotrexate; Methylprednisolone; Recurrence | 2023 |
Autoimmune inner ear disease.
Topics: Adrenal Cortex Hormones; Animals; Autoimmune Diseases; Cyclophosphamide; Female; Hearing Loss, Sensorineural; Humans; Labyrinth Diseases; Male; Methotrexate; Mice; Plasmapheresis; Prognosis; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2000 |
1 trial(s) available for methotrexate and Labyrinth Diseases
| Article | Year |
|---|---|
Immune-mediated inner ear disease and parvovirus B19.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Antibodies, Viral; Autoimmune Diseases; Child; Child, Preschool; Cyclophosphamide; Erythema Infectiosum; Female; Hearing Loss, Sensorineural; Humans; Immunosuppressive Agents; Labyrinth Diseases; Male; Methotrexate; Middle Aged; Parvovirus B19, Human; Vestibular Diseases | 1994 |
3 other study(ies) available for methotrexate and Labyrinth Diseases
| Article | Year |
|---|---|
Diffuse systemic sclerosis presenting as Meniere's disease-like symptoms as part of autoimmune inner ear disease.
Topics: Adult; Anti-Inflammatory Agents; Antirheumatic Agents; Arrhythmias, Cardiac; Diagnosis, Differential; Disease Progression; Fatal Outcome; Female; Hearing Loss, Sensorineural; Humans; Labyrinth Diseases; Meniere Disease; Methotrexate; Monitoring, Immunologic; Prednisone; Scleroderma, Systemic | 2015 |
Autoimmune inner ear disease in children.
Topics: Adolescent; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Auditory Threshold; Autoimmune Diseases; Blotting, Western; Bone Conduction; Child; Child, Preschool; Cyclophosphamide; Female; Hearing Loss, Sensorineural; Hematologic Tests; HLA-DR4 Antigen; Humans; Labyrinth Diseases; Male; Methotrexate; Prednisone; Retrospective Studies; Speech Perception; Steroids | 2011 |
Unusual and instructive case of immune-mediated inner ear disease associated with central nervous system vasculitis.
Topics: Adult; Autoimmune Diseases; Female; Glucocorticoids; Hearing Loss, Sensorineural; Humans; Immunosuppressive Agents; Labyrinth Diseases; Methotrexate; Prednisone; Vasculitis, Central Nervous System | 2000 |